Background: Nonspecific tumor targeting, potential relapse and metastasis of tumor after
treatment are the main barriers in clinical photodynamic therapy (PDT) for cancer, hence …

We designed a cancer-cell specific photosensitizer nano-carrier by synthesizing
pheophorbide a (PheoA) conjugated glycol chitosan (GC) with reducible disulfide bonds …

To achieve a tumor-targeted drug delivery system for photodynamic therapy, we designed
ligand-mediated nanoparticles with stable formulations of a hydrophobic photosensitizer …

Herein, we developed the photosensitizer, protoporphyrin IX (PpIX), conjugated glycol
chitosan (GC) nanoparticles (PpIX–GC–NPs) as tumor-homing drug carriers with cellular …

Background Photodynamic therapy (PDT), a clinical anticancer therapeutic modality, has a
long history in clinical cancer treatments since the 1970s. However, PDT has not been …

Nanocarrier-mediated photodynamic therapy (PDT) is an effective tool for anti-tumour
treatment due to the targeted and image-guided delivery of photosensitizers (PSs) to …

An effective tumor-targeted drug delivery system for photodynamic therapy was developed
by designing ligand-mediated nanoparticles with stable formulations of a hydrophobic …

The development of enzyme-activatable photosensitizers and their combination with
conventional chemodrugs for antitumor therapy are of great interest. In this work, we …

Photodynamic therapy (PDT) has been emerged as an alternative therapeutic modality in
treatment of several malignant tumors. However, the therapeutic efficacy of PDT is often …

Photodynamic therapy (PDT) is considered an innovative and attractive modality to treat
ovarian cancer. In the present study, a biodegradable polymer poly (ethylene glycol)(PEG) …